Hepatitis B and Hepatitis C Seroprevalance in Center of Sanliurfa Province From Souteastern Anatolia Region and Related Risk Factors

Medical Journal of Trakya University
doi 10.5174/tutfd.2009.02533.0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Galenos Yayinevi

Related search

Statins and Risk of Decompensation in Hepatitis B Virus- And Hepatitis C Virus-Related Cirrhosis: Methodological Issues

Hepatology
MedicineHepatology
2018English

Seroprevalance of Hepatitis B Virus, Human Immunodeficiency Virus and Hepatitis C Virus Among Blood Donors: A Retrospective Study

Tropical Journal of Pathology and Microbiology
2019English

Risk Factors Influencing Dentists’ Hepatitis B-Related Knowledge and Attitudes and Their Willingness to Treat Hepatitis B Positive Patients

Eastern Mediterranean Health Journal
Medicine
2015English

Risk Factors of Chronic Hepatitis in Antiretroviral-Treated HIV Infection, Without Hepatitis B or C Viral Infection

AIDS Research and Therapy
VirologyMolecular MedicinePharmacology
2013English

Distribution and Risk Factors of Hepatitis B, Hepatitis C, and HIV Infection in a Female Population With "Illegal Social Behaviour"

Sexually Transmitted Infections
DermatologyInfectious Diseases
2005English

Hepatitis B and C Infection in Haemodialysis Patients in Libya: Prevalence, Incidence and Risk Factors

BMC Infectious Diseases
Infectious Diseases
2012English

Statins Decrease the Risk of Decompensation in Hepatitis B Virus- And Hepatitis C Virus-Related Cirrhosis: A Population-Based Study

Hepatology
MedicineHepatology
2017English

Hepatitis B and C Viruses

2019English

Reply: Statins Decrease the Risk of Decompensation in Hepatitis B Virus- And Hepatitis C Virus-Related Cirrhosis: A Population-Based Study

Hepatology
MedicineHepatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy